Institute of Isotopes Co. Ltd. of Budapest at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Institute of Isotopes Co. Ltd.

P.O. Box 851, 1535 Budapest
Konkoly-Thege M. U. 29-33., 1121 Budapest
Telephone +36 1 3922577
Fax +36 1 3959247

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Hall map

MEDICA 2021 hall map (Hall 1): stand A49

Fairground map

MEDICA 2021 fairground map: Hall 1


Szabolcs Szakaly

Director of Sales and Purchase



Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Our range of products

Product categories

  • 01  Imaging and diagnostics / medical equipment and devices
  • 01.02  Imaging supplies
  • 01.02.01  Nuclear diagnostics equipment

Nuclear diagnostics equipment

  • 03  Diagnostic tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.01  Immuno assay testing

Immuno assay testing

Our products

Product category: Immuno assay testing



(REF: RK-38CT)

The 125I‑hCEA IRMA system provides a direct in vitro quantitative determination of human carcinoembryonic antigen (hCEA) in human serum in the range of 0-180 ng/mL. Each kit contains materials sufficient for 100 assay tubes permitting the construction of one standard curve and the assay of 41 unknowns in duplicate.

Carcinoembryonic antigen (CEA) is a cell-surface glycoprotein with a molecular weight of 180-200kD, that occurs in high levels in colon epithelial cells during embryonic development. Levels of CEA are significantly lower in colon tissue of adults, but can become elevated when inflammation or tumours arise in any endodermal tissue, including in the gastrointestinal tract, respiratory tract, pancreas and breast.

An overexpression of CEA protein has been detected in a variety of adenocarcinomas, including gastric, pancreatic, small intestine, colon, rectal, ovarian, breast, cervical and non-small-cell lung cancers. CEA is also expressed by epithelial cells in several non-malignant disorders, including diverticulitis, pancreatitis, inflammatory bowel disease, cirrhosis, hepatitis, bronchitis and renal failure and also in heavy smokers.

Therefore CEA should not be regarded as a tumour-specific marker for the screening of general population for undetected cancers. However, the determination of CEA levels provides important information about patient prognosis, recurrence of tumours after surgical removal and effectiveness of therapy.

More Less

About us

Company portrait

Immunoassay kits for diagnostic (thyroid function, steroid/protein hormones, tumor markers) and research purposes (RIA/IRMA/ELISA); Radiopharmaceuticals, Tc-labelled cold kits, Radiochemicals; Synthesis of C-14 labelled compounds, Radiation Technique

Company data

Sales volume 10-49 Mio US $
Export content > 75%
Number of employees 100-499
Foundation 1993
Area of business
  • Imaging and diagnostics / medical equipment and devices
  • Diagnostic tests

Company information as a PDF file